JPH0325760B2 - - Google Patents
Info
- Publication number
- JPH0325760B2 JPH0325760B2 JP56095884A JP9588481A JPH0325760B2 JP H0325760 B2 JPH0325760 B2 JP H0325760B2 JP 56095884 A JP56095884 A JP 56095884A JP 9588481 A JP9588481 A JP 9588481A JP H0325760 B2 JPH0325760 B2 JP H0325760B2
- Authority
- JP
- Japan
- Prior art keywords
- hydrated
- oxide
- tin oxide
- item
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 claims description 36
- 229910001887 tin oxide Inorganic materials 0.000 claims description 22
- 239000003480 eluent Substances 0.000 claims description 19
- 239000003463 adsorbent Substances 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 229910019142 PO4 Inorganic materials 0.000 claims description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- 239000002245 particle Substances 0.000 claims description 6
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 6
- 239000010452 phosphate Substances 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 5
- 238000010828 elution Methods 0.000 claims description 5
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 4
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 claims description 4
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims description 4
- -1 polyantimonate Chemical compound 0.000 claims description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 235000021317 phosphate Nutrition 0.000 description 11
- QHGNHLZPVBIIPX-UHFFFAOYSA-N tin(ii) oxide Chemical class [Sn]=O QHGNHLZPVBIIPX-UHFFFAOYSA-N 0.000 description 10
- 229910006404 SnO 2 Inorganic materials 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 6
- IGLNJRXAVVLDKE-OIOBTWANSA-N Rubidium-82 Chemical compound [82Rb] IGLNJRXAVVLDKE-OIOBTWANSA-N 0.000 description 4
- 239000000022 bacteriostatic agent Substances 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000009206 nuclear medicine Methods 0.000 description 2
- 239000000700 radioactive tracer Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 229910052701 rubidium Inorganic materials 0.000 description 2
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- CIOAGBVUUVVLOB-VENIDDJXSA-N strontium-82 Chemical compound [82Sr] CIOAGBVUUVVLOB-VENIDDJXSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229910018626 Al(OH) Inorganic materials 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical group OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- GYHNNYVSQQEPJS-YPZZEJLDSA-N Gallium-68 Chemical compound [68Ga] GYHNNYVSQQEPJS-YPZZEJLDSA-N 0.000 description 1
- 101100208721 Mus musculus Usp5 gene Proteins 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical class OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 230000003727 cerebral blood flow Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical group [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 150000004677 hydrates Chemical class 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000000644 isotonic solution Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000012217 radiopharmaceutical Substances 0.000 description 1
- 229940121896 radiopharmaceutical Drugs 0.000 description 1
- 230000002799 radiopharmaceutical effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Treatment Of Liquids With Adsorbents In General (AREA)
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16285880A | 1980-06-25 | 1980-06-25 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5730545A JPS5730545A (en) | 1982-02-18 |
JPH0325760B2 true JPH0325760B2 (enrdf_load_stackoverflow) | 1991-04-08 |
Family
ID=22587416
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP9588481A Granted JPS5730545A (en) | 1980-06-25 | 1981-06-19 | 82rb generating method and adsorbent composition |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS5730545A (enrdf_load_stackoverflow) |
ZA (1) | ZA813677B (enrdf_load_stackoverflow) |
-
1981
- 1981-06-02 ZA ZA00813677A patent/ZA813677B/xx unknown
- 1981-06-19 JP JP9588481A patent/JPS5730545A/ja active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5730545A (en) | 1982-02-18 |
ZA813677B (en) | 1982-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Guhlke et al. | Simple new method for effective concentration of 188Re solutions from alumina-based 188W—188Re Generator | |
AU663716B2 (en) | Tungsten-188/carrier-free rhenium-188 perrhenic acid generator system | |
US4406877A (en) | 82 Rb Generating method and eluent | |
EA005735B1 (ru) | Получение сверхчистого висмута-213 для использования в терапевтической ядерной медицине | |
EP0043650B1 (en) | Method and adsorbant composition for 82 rb generation | |
Knapp Jr et al. | Use of new tandem cation/anion exchange system with clinical-scale generators provides high specific volume solutions of technetium-99m and rhenium-188 | |
CA1252621A (en) | Strontium-82/rubidium-82 generator | |
Lee et al. | Development of a high performance 188W/188Re generator by using a synthetic alumina | |
US5729821A (en) | Concentration of perrhenate and pertechnetate solutions | |
Neirinckx et al. | Evaluation of inorganic adsorbents for the rubidium-82 generator: I. Hydrous SnO2 | |
Chattopadhyay et al. | A novel 99mTc delivery system using (n, γ) 99Mo adsorbed on a large alumina column in tandem with Dowex-1 and AgCl columns | |
JPH0325760B2 (enrdf_load_stackoverflow) | ||
Mansur et al. | Concentration of 99mTc-pertechnetate and 188Re-perrhenate | |
Bokhari et al. | Concentration of 188Re-Perrhenate for therapeutic radiopharmaceuticals | |
US20240076248A1 (en) | Method for purification of radiolabeled macroaggregated human serum albumin | |
RU2778249C1 (ru) | Способ генераторного получения висмута-213 через отделение и распад франция-221 | |
Panek et al. | A new generator for production of short-lived Au-195m radioisotope | |
JP2002535113A (ja) | 放射性ヨウ化物同位体の精製および濃縮方法 | |
Knapp et al. | Concentration of perrhenate and pertechnetate solutions | |
Basmanov et al. | The Development of Chromatographic 188W/188Re Generators for Therapy | |
Zhernosekov | Radiochemical aspects of production and processing of radiometals for preparation of metalloradiopharmaceuticals | |
Xiaohai et al. | Preparation of 188W/188Re generator in a clinical-scale | |
Sn02 | RADIOCHEMISTRYAND RADIOPHARMACEUTICALS | |
Xiaohai et al. | Preparation of {sup 188} W/{sup 188} Re generator in a clinical-scale | |
Malja et al. | 90Y-preparation and some preliminary results on labelling of radiopharmaceuticals |